Indication
Bronchitol is indicated for the treatment of cystic fibrosis (CF) in adults aged 18 years and above as an add-on therapy to best standard of care.
Loading your page…
Loading your page…
Cystic Fibrosis
Marketing Authorisation Holder: Pharmaxis Europe Limited
EMA Authorisation: 13/04/2012
INN: mannitol
AI Drug & Interaction Analysis
Free account required
Ask Osler about Bronchitol: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.